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Solid-organ transplantation began in South Africa 
(SA) when the first kidney transplant was performed 
at the old Johannesburg Hospital on 25 August 1966.[1] 
In 1973, the only centres offering transplantation were 
in the public sector, namely Johannesburg General, 
Baragwanath, Addington, HF Verwoerd and Groote Schuur hospitals. 
By 1982, Universitas and Tygerberg hospitals had commenced 
transplantation.[2,3] There are now 18 transplant centres throughout SA, 
eight in the public sector and ten in the private sector. It is noteworthy 
that all these centres are clustered in large urban settings and are 
located in only four of the nine provinces in SA, making access to 
transplantation relatively inequitable.[4]
Wits Donald Gordon Medical Centre (WDGMC), University of 
the Witwatersrand, Johannesburg, SA, is a private academic teaching 
hospital. In 2004, a solid-organ transplant unit was established that 
now offers adult and paediatric kidney, simultaneous kidney-pancreas 
(SKP), pancreas alone (PA), pancreas after kidney (PAK), liver and 
combined liver-kidney (CLK) transplantation. Liver, kidney and SKP 
transplants have been performed since 2004, CLK transplantation 
began in 2007, a hand-assisted laparoscopic live donor nephrectomy 
(HALLDN) programme was introduced in 2008, and pancreas-
only transplantation (PA/PAK) has been performed since 2012. A 
paediatric living-donor liver transplant programme was started in 
2013 and is currently the only such programme in southern Africa.
Many international centres that participate in transplantation 
programmes are obliged to report outcomes annually to a national 
registry. Unfortunately, the South African Dialysis and Transplant 
Registry last published national transplant survival data in 1994. The 
Organ Donor Foundation (ODF) collects annual transplant statistics 
for SA, but this reporting is voluntary and does not include survival. 
Outcomes for paediatric liver transplantation in the Johannesburg 
region have recently been published.[5] An audit of the adult liver 
transplantation programme in Johannesburg will be published 
separately. The focus of this article is on reporting recipient and 
graft survival from kidney and pancreas transplantation at WDGMC 
during the first 10 years.
Methods
A retrospective review was conducted of all kidney and pancreas 
transplants performed at WDGMC from 1 January 2004 to 31 Decem-
ber 2013. Permission to conduct the review was granted by the 
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Background. It is important for centres participating in transplantation in South Africa (SA) to audit their outcomes. Wits Donald Gordon 
Medical Centre (WDGMC), Johannesburg, SA, opened a transplant unit in 2004. The first 10 years of kidney and pancreas transplantation 
were reviewed to determine outcomes in respect of recipient and graft survival.
Methods. A retrospective review was conducted of all kidney-alone and simultaneous kidney-pancreas (SKP) transplants performed 
at WDGMC from 1 January 2004 to 31 December 2013, with follow-up to 31 December 2014 to ensure at least 1 year of survival data. 
Information was accessed using the transplant registers and clinical records in the transplant clinic at WDGMC. The Kaplan-Meier method 
was used to estimate 1-, 5- and 10-year recipient and graft survival rates for primary (first graft) kidney-alone and SKP transplants.
Results. The overall 10-year recipient and graft survival rates were 80.4% and 66.8%, respectively, for kidney-alone transplantation. In 
the kidney-alone group, children tended towards better recipient and graft survival compared with adults, but this was not statistically 
significant. In adults, recipient survival was significantly better for living than deceased donor type. Recipient and graft survival were 
significantly lower in black Africans than in the white (largest proportion in the sample) reference group. For SKP transplants, the 10-year 
recipient survival rate was 84.7%, while kidney and pancreas graft survival rates were 73.1% and 43.2%, respectively.
Conclusion. Outcomes of the first 10 years of kidney and pancreas transplantation at WDGMC compare favourably with local and 
international survival data.
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(Medical) (M140647). Data were extracted 
from regu latory registers and patient 
records in the transplant clinic, from on-site 
pathology laboratories for blood results, 
and from patient records from participating 
doctors at WDGMC and in clinical practice 
outside the hospital, all of whom were 
involved in the long-term care of recipients 
after transplantation. All the patients who 
underwent transplants were funded by private 
medical insurance. Where necessary, clinicians 
were contacted regarding survival of their 
patients and the most recent laboratory test 
results were obtained for the survival analyses.
Data comprised the total number of 
trans plants, repeat transplants, solid organs 
transplanted, recipient age (adults were 
defined as ≥18 years), gender, ethnicity, 
date of transplant, donor type (deceased 
v. living) and duration of post-transplant 
follow-up. In the case of deceased donation, 
all donors were heart-beating and brain-
dead; there was no donation after cardiac 
death. SKP transplantation was only offered 
to patients with type 1 diabetes who had 
been rigorously screened to exclude vascular 
disease before transplantation.
Kaplan-Meier recipient and graft survival 
analyses were conducted for transplants 
carried out during the study period, with at 
least 1 year of follow-up of all recipients. Those 
who had died or were lost to follow-up were 
censored in the graft survival analyses. Data 
were not censored for death with a functioning 
graft. Kidney graft survival, for the primary 
(first) graft only, was determined by the latest 
available serum creatinine level, and graft loss 
was defined by the date of commencement 
of post-transplant chronic dialysis, graft 
removal, retransplantation or death. Pancreas 
graft loss was defined by the date of surgical 
removal of the organ, commencement of 
insulin therapy if the graft was in situ, or death. 
Survival analysis for pancreas recipients only 
included adult SKP transplants, as the numbers 
of pancreas-only and paediatric pancreas 
recipients were very small.
Cox proportional hazards regression 
was used for between-group comparisons 
for adult v. paediatric recipients, living v. 
deceased donors, gender and ethnicity. Self-
reported ethnicity was categorised as Asian, 
black African, mixed or white. Because 
numbers of recipients of mixed ethnicity 
were small and none of them had reached 
10 years of follow-up, these patients were 
excluded from the between-group ethnicity 
survival analysis. The 5% significance level 
was used throughout and analysis was 
carried out using SAS version 9.4 (SAS 
Institute Inc., USA). National statistics were 
obtained from the ODF annual reports.
Results
During the study period, WDGMC per-
formed 15.2% (368/2 424) of all kidney 
transplants and 79.1% (72/91) of all 
pancreas (PA, PAK, SKP) transplants in 
SA. Of the kidney-alone recipients, 96.5% 
(355/368) received a primary graft and 
3.0% (11/368) a second graft, two recipients 
(0.5%) receiving a third graft. The total 
number of paediatric kidney-alone 
recipients comprised 51/368 (13.9%), and 
all except one received primary grafts. After 
introduction of the HALLDN programme 
in 2008, 73.4% (94/128) of all living-
donor nephrectomies were performed 
using this technique. Of all the pancreas 
transplants performed, 93.1% (67/72) 
were SKP transplants, 5.5% (4/72) were 
PAK transplants and one (1.4%) was a 
PA transplant. Only one paediatric SKP 
transplant occurred during this period.
The demographics and recipient and 
graft survival rates for all primary kidney-
alone transplants are shown in Table 1. 
For primary kidney-alone transplantation, 
the male/female ratios were 1.6 and 1.8 
for children and adults, respectively. In the 
paediatric group the most common source 
of the organ was a live donor (64.0%), while 
deceased donation predominated in adults 
(60.0%).
Overall, the 1-year primary kidney-
alone survival rate was 94.2% for recipients 
and 91.7% for grafts. After 10 years, 
80.4% of recipients had survived with a 
corresponding 66.8% survival of their grafts. 
When looking at Kaplan-Meier survival of 
subgroups within the primary kidney-alone 
transplants, the paediatric group tended 
towards better recipient and graft survival 
compared with adults, but this was not 
statistically significant. Among the adults, 
there were no significant gender differences 
for recipient (p=0.69) or graft (p=0.40) 
survival. Survival of adult living-donor 
recipients was significantly better than that 
of deceased-donor recipients (p=0.047; 
hazard ratio (HR) 0.48; 95% confidence 
Table 1. Demographics and 1-, 5- and 10-year patient and graft survival for primary 
kidney-alone transplants performed at WDGMC, 2004 - 2013
Variable Overall 0 - 17 years ≥18 years
Recipients, N 355 50 305
Age (years), mean (SD) 10.3 (4.1) 42.3 (12.3)
Donor type, n (%)
NRLD 31 (8.7) 2 (4.0) 29 (9.5)
RLD 123 (34.6) 30 (60.0) 93 (30.5)
Deceased 201 (56.7) 18 (36.0) 183 (60.0)
Gender, n (%)
Female 130 (36.6) 19 (38.0) 111 (36.4)
Male 224 (63.1) 30 (60.0) 194 (63.6)
Unknown 1 (0.3) 1 (2.0) 0 (0.0)
Ethnicity, n (%)
Asian 40 (11.3) 6 (12.0) 34 (11.1)
Black African 123 (34.6) 16 (32.0) 107 (35.1)
Mixed 19 (5.4) 3 (6.0) 16 (5.3)
White 156 (43.9) 22 (44.0) 134 (43.9)
Unknown 17 (4.8) 3 (6.0) 14 (4.6)
1-year survival, % (95% CI)
Patient 94.2 (91.3 - 96.3) 98.0 (86.6 - 99.7) 93.7 (90.3 - 95.9)
Kidney 91.7 (88.3 - 94.1) 93.8 (82.0 - 98.0) 91.3 (87.5 - 94.0)
5-year survival, % (95% CI)
Patient 87.8 (83.4 - 91.1) 98.0 (86.6 - 99.7) 86.1 (81.1 - 89.9)
Kidney 80.3 (74.9 - 84.7) 87.7 (72.0 - 94.9) 79.1 (73.1 - 83.9)
10-year survival, % (95% CI)
Patient 80.4 (70.5 - 87.2) 98.0 (86.6 - 99.7) 77.9 (67.0 - 85.5)
Kidney 66.8 (55.0 - 76.1) 87.7 (72.0 - 94.9) 64.6 (52.1 - 74.6)
NRLD = non-related living donor; RLD = related living donor.
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interval (CI) 0.24 - 0.99) (Fig. 1). There 
was no difference in graft survival when 
comparing living v. deceased donor type 
(p=0.11). Survival of adult black recipients 
was significantly worse than the reference 
group of white recipients (p=0.038; HR 2.05; 
95% CI 1.04 - 4.03) (Fig. 2). Similarly, kidney 
graft survival was significantly worse in 
adult black recipients (p=0.042; HR 1.78; 
95% CI 1.02 - 3.09) and significantly better 
in Asian recipients (p=0.035; HR 0.12; 95% 
CI 0.02 - 0.86) compared with the reference 
group of white recipients (Fig. 3).
The demographics and recipient and graft 
survival rates for all adult SKP transplants 
are shown in Table 2. In the adult SKP 
group (n=66), the male/female ratio was 
0.69. Overall, for adult SKP transplants 
the 10-year recipient, kidney and pancreas 
survival rates were 84.7%, 73.1% and 43.2%, 
respectively. The Kaplan-Meier survival 
curves are depicted in Fig. 4.
Discussion
Overall, both 1-year recipient and graft 
survival rates for kidney-alone trans-
plantation at WDGMC were >90%. The 
10-year survival rate for kidney-alone trans-
plantation was 80.4% for recipients and 
66.8% for grafts. In the adults, recipient 
survival was better for living-donor 
recipients, and both recipient and graft 
survival were worse in the black population. 
The 10-year survival rates for adult SKP 
transplantation at WDGMC for recipient, 
kidney and pancreas were 84.7%, 73.1% and 
43.2%, respectively.
Outcomes for adult kidney-alone trans-
plantation at WDGMC compare favourably 
with international transplant centres. The 
adult 10-year graft survival rate (64.6%) was 
similar to that reported for Spain (71.3%) in 
a recent review that compared outcomes in 
the USA with those in Spain,[6] and better 
than that reported for the USA (53.4%). 
Similarly, 10-year recipient survival (77.9%) 
was comparable to that in Spain (86.2%) and 
superior to that in the USA (67.4%).[6]
In the adult primary kidney transplant 
group, the significantly worse outcomes 
for black recipients and their grafts paral-
leled outcomes seen in African Americans. 
Deceased donor graft survival in African 
Americans has been shown to be signifi-
cantly worse than that observed for other 
ethnic groups (Europeans, Hispanics and 
white Americans), and this difference was 
accentuated 5 and 10 years after transplan-
tation.[7] Our results, although similar to 
those for African Americans at 5 and 10 
years after transplantation, contradict find-
ings from a study at Tygerberg Hospital in 
Cape Town, where no significant difference 
in graft survival based upon ethnicity was 
found. However, the period under review 
at Tygerberg was earlier than in this study 
and there were far fewer black recipients 
(n=56/542 (10.3%).[8]
A host of factors have been proven to 
pre dispose African Americans to poorer 
graft outcomes. For example, Medicare 
health funder policy only finances immuno-
suppressant medication for the first 3 years 
after transplantation, which forces patients 
to buy their own expensive medication 
thereafter. Consequently com pliance falls, 
contri buting to graft loss. African Americans 
have lower rates of living-related donation, 
and higher rates of immunological rejection 
and HLA mismatching, and persistent hyper-
tension after the transplant.[9,10] Recently 
identified genetic mutations in the APOL1 
gene in African American living donors 
may also impact adversely on graft function 
after donation.[11,12] Our preliminary findings 
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Fig. 1. Kaplan-Meier recipient and graft survival for adult primary kidney-alone transplants at 
WDGMC, 2004 - 2013 (living v. deceased donor type). 
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Fig. 2. Kaplan-Meier recipient survival for adult primary kidney-alone transplants at WDGMC, 
2004 - 2013 (by ethnicity).
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highlight the need for rigorous research 
into the SA kidney transplant donor and 
recipient community in order to determine 
population-specific factors that influence 
outcomes.
The paediatric primary kidney recipient 
and graft survival in this cohort was 
excellent, with >90% recipient and >85% 
graft survival at 10 years. However, the 
estimates are not very precise because of 
the small number of children who have 
had transplants so far. Charlotte Maxeke 
Johannesburg Academic Hospital (CMJAH) 
reviewed 282 paediatric transplants from 
1984 to 2003.[13] Ten-year recipient and 
graft survival rates were 68% and 23%, 
respectively. Red Cross War Memorial 
Children’s Hospital (RCWMCH) in Cape 
Town reviewed 89 transplants from 1995 to 
2005 and found the 7-year graft survival rate 
to be 72%.[14] In a recent publication from the 
USA that reviewed 17 000 paediatric kidney 
transplants, outcomes were significantly 
better after 2001, which may be related 
to better immunosuppression, with 10-year 
recipient and graft survival rates of 90.5% 
and 60.2%, respectively.[15] Explanations for 
the relatively good survival in our cohort, 
given that it is still a small sample, may 
reflect the more ‘recent’ time frame of 
analysis; higher living donor rates (64%) 
compared with 24% at RCWMCH and 21% 
at CMJAH; fewer black children, who have 
been shown to have poorer graft survival; 
fewer repeat transplants; and the assumption 
that socioeconomic circumstances are better 
in patients accessing a funded healthcare 
environment.[16]
SKP transplantation is considered the 
treatment of choice for type 1 diabetics 
with end-stage kidney disease who are 
<50 years of age. [17,18] There is, however, 
a debate around this in the literature, 
because some centres have shown inferior 
survival for SKP transplantation when 
compared with living donor kidney-alone 
transplantation in type 1 diabetics with 
end-stage kidney disease.[19] Unfortunately 
Table 2. Demographics and 1-, 5- and 
10-year patient and graft survival for 
SKP transplants performed at WDGMC 
in adults, 2004 - 2013
Variable
Gender, n (%)
Female 39 (59.1)
Male 27 (40.9)
Ethnicity, n (%)
Asian 3 (4.6)
Black African 7 (10.6)
Mixed 2 (3.0)
White 48 (72.7)
Unknown 6 (9.1)
Age (years) mean (SD) 34.6 (6.1)
1-year survival, %  
(95% CI)
Patient 97.0 (88.4 - 99.2)
Kidney 97.0 (88.4 - 99.2)
Pancreas 86.1 (75.0 - 92.5)
5-year survival, %  
(95% CI)
Patient 84.7 (72.5 - 91.8)
Kidney 73.1 (58.2 - 83.5)
Pancreas 62.6 (48.5 - 73.8)
10-year survival, % 
(95% CI)
Patient 84.7 (72.5 - 91.8)
Kidney 73.1 (58.2 - 83.5)
Pancreas 43.2 (24.5 - 60.6)
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Fig. 3. Kaplan-Meier graft survival for adult primary kidney-alone transplants at WDGMC, 2004 - 
2013 (by ethnicity).
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Fig. 4. Kaplan-Meier recipient and graft survival for SKP transplants at WDGMC, 2004 - 2013.
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we do not have sufficient numbers of type 1 diabetics who received 
a kidney-alone transplant to compare their outcomes with the SKP 
group, but adult recipient and kidney graft survival rates in the 
SKP group were comparable to those in the kidney-alone group 
(Table 2). Pancreas survival at 5 years is commonly >60%, and this 
was also observed in this series.[20] Ten-year survival data, although 
more scarce, are generally >50%, which is in line with this cohort 
at 43.2% (95% CI 24.5 - 60.6).
Study limitations
There are limitations to this study. Firstly, the annual national 
statistics from the ODF rely on voluntary reporting of transplant 
activity from individual transplant units. Although the ODF is the 
only available source of national transplant statistics, these may not 
accurately reflect transplant activity if units do not submit data, or 
submit incomplete or inaccurate data. Annual reports are compiled 
and returned to participating units after data submission. There were 
some minor discrepancies when comparing data from the WDGMC 
registers with ODF national statistics. The transplant statistics in 
this article were from the WDGMC registers/recipient records in 
preference to ODF statistics, as the former have been accurately 
verified.
Secondly, the numbers of patients who underwent transplants in 
this series were relatively small and this prevented us from doing 
further analyses to understand some of the findings, for example 
exploring the observed differences in outcomes for black v. white 
recipients and their grafts. Unfortunately no further analysis of 
deceased v. living donor graft survival in black recipients was possible 
owing to the small numbers of patients at 5 and 10 years after 
the transplant. This also limited comparisons with larger cohorts 
internationally.
Conclusion
Outcomes of kidney and pancreas transplantation for the first 10 
years at WDGMC compare favourably with local and international 
data. Further research is required into the SA donor and recipient 
pool to identify specific risk factors that could be addressed to 
improve recipient and graft survival.
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